Evidence map›Paper›PMID 41991640›Full record

ArticleScientific reports2026

Cross-species metabolic characterization of eutylone and mechanism-based inhibition of CYP2D6 and CYP2B6 with drug interaction implications.

Min Seo Lee, Im-Sook Song, Yeonsu Jang, Yong-Yeon Cho, Joo Young Lee, Han Chang Kang, Ju-Hyun Kim, Hye Suk Lee

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Min Seo Lee *College of Pharmacy, The Catholic University of Korea, Bucheon, 14662, Republic of Korea.
Im-Sook Song *BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, Vessel-Organ Interaction Research Center (VOICE), Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, 41566, Republic of Korea.
Yeonsu JangCollege of Pharmacy, Yeungnam University, Gyeongsan, 38541, Republic of Korea.
Yong-Yeon ChoCollege of Pharmacy, The Catholic University of Korea, Bucheon, 14662, Republic of Korea.
Joo Young LeeCollege of Pharmacy, The Catholic University of Korea, Bucheon, 14662, Republic of Korea.
Han Chang KangCollege of Pharmacy, The Catholic University of Korea, Bucheon, 14662, Republic of Korea.
Ju-Hyun KimCollege of Pharmacy, Yeungnam University, Gyeongsan, 38541, Republic of Korea. jhkim@yu.ac.kr.
Hye Suk LeeCollege of Pharmacy, The Catholic University of Korea, Bucheon, 14662, Republic of Korea. sianalee@catholic.ac.kr.

Funding

National Research Foundation of Korea NRF-2023R1A2C2007632National Research Foundation of Korea RS-2026-25479461
6 · The paper itself

Abstract

Eutylone is a methylenedioxy-substituted synthetic cathinone increasingly detected in toxicological case analyses and commonly encountered under polydrug use conditions. To support metabolism-informed surveillance and risk assessment of emerging stimulants, this study comprehensively characterized eutylone disposition and interaction liability using plasma protein binding, metabolic stability in liver microsomes and hepatocytes across four species, untargeted feature-based molecular networking-based metabolite profiling, CYP phenotyping, and reversible and time-dependent inhibition assays. Eutylone exhibited moderate plasma protein binding (f

Indexed as

Cytochrome P-450 CYP2B6Cytochrome P-450 CYP2B6 InhibitorsCytochrome P-450 CYP2D6Cytochrome P-450 CYP2D6 InhibitorsSynthetic CathinoneAnimalsBenzodioxolesDogsDrug InteractionsEthylaminesHepatocytesHumansMaleMiceMicrosomes, LiverRatsBenzodioxolesCytochrome P-450 CYP2B6Cytochrome P-450 CYP2B6 InhibitorsCytochrome P-450 CYP2D6Cytochrome P-450 CYP2D6 InhibitorsEthylamineseutyloneSynthetic CathinoneCYPDrug-drug interactionEutyloneMetabolismMetabolite

Identifiers

PMID41991640
PMCPMC13243497

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.